Answers are grounded in this paper and cite their sources.
Multiple myeloma (MM) patients are considered severely immune-compromised and at high risk of opportunistic infections, independently of the therapeutic approach and the response status.
No takes yet. Share an insight, caveat, or question.
Ziogas et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: